ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More

The American Society of Clinical Oncology meeting in Chicago has wrapped up for another year.

This week, we’ll wrap up ASCO with highlights and context on the immunotherapy wins and losses, the continued push toward more genetically focused pills, the first glimpses of data from places cancer treatment has never been, and a step up in the race to make blood tests to find cancer in otherwise healthy people.